15
Jan
2025
New study highlights PExA’s potential as a novel method for non-invasive measurement of drug levels in the lung
A new study published in the Journal of Aerosol Medicine and Pulmonary Drug Delivery showcases a potential breakthrough in lung pharmacokinetics (PK) research using the PExA® instrument developed by PExA AB. The study, titled “Assessing human lung pharmacokinetics using exhaled breath particles,” demonstrates the feasibility of utilizing exhaled breath particles (PEx) for non-invasive measurement of…
Read more